ArticleAdvances in therapy2023

Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison.

Josep-Maria Ribera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.